Cold air, dust and autumn walks can turn a harmless atchoo into a nagging puzzle for worried dog owners. A quick sneeze now ...

The patient - let's call her Melanie - in my consulting room looked absolutely mortified. 'What seems to be the problem,' I ...

Cold mornings, radiators humming, and a chorus of snorts from the sofa raise quiet doubts in countless British homes. As ...

Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published ...

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...

The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab -ekko) has been approved in the US for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with inadequately ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Nasacort takes up to a week to achieve full benefits for allergy symptoms, and should be used daily for optimal allergy relief. Here's what you need to know about the safety and risks of using this ...

Singer Seo In-young has drawn attention for her candid updates shared during a recent live broadcast on her social media account. The artist, who announced her divorce last November, appeared more ...

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...